SCHEMBL22633970

SCHEMBL22633970

O=C(S)NN1C(=O)c2ccccc2C1=O

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.62
▸ KDM4E B2RXH2 3/20 0.62
▸ MAPT P10636 2/20 0.62
▸ RAB9A P51151 2/20 0.62
▸ NPSR1 Q6W5P4 1/20 0.62
▸ MEN1 O00255 5/20 0.56
▸ KMT2A Q03164 5/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ PTGS1 P23219 1/20 0.56
▸ PTGS2 P35354 1/20 0.56
▸ LMNA P02545 3/20 0.54
▸ CYP2C19 P33261 1/20 0.53
▸ CYP1A2 P05177 1/20 0.48
▸ PKM P14618 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11530550 0.83 ALDH1A1 (0.61) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL1512585 0.81 MEN1 (0.62) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL17690051 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL22649378 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL5542522 0.79 RAB9A (0.71) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL9146128 0.76 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL30423816 0.76 MEN1 (0.79) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL11817094 0.76 MEN1 (0.79) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL22633972 0.75 MEN1 (0.56) ALDH1A1KDM4EMAPTRAB9ANPSR1
SCHEMBL13154822 0.75 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTRAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 — — US disclosed
WO-2020227592-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC ALDH1A1 981/4885KDM4E 2658/4885MAPT 1493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback